Celgene, Versant back a biotech merger, building an antibody pipeline and lining up for the clinic
Versant Ventures and Celgene have extended their deal to foster a Toronto-based biotech called Northern Biologics, bringing in a Phase I-ready cancer drug through a …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.